Equities Analysts Issue Forecasts for NTLA FY2027 Earnings
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) – Research analysts at Wedbush raised their FY2027 earnings estimates for Intellia Therapeutics in a report released on Thursday, October 30th. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings of ($2.80) per share for the year, up from their previous forecast of ($2.90). The […]
4 Nov 08:22 · The Markets Daily